Tuesday, 13 January 2009

Reclipsen




In the US, Reclipsen (desogestrel/ethinyl estradiol systemic) is a member of the drug class contraceptives and is used to treat Abnormal Uterine Bleeding, Birth Control, Endometriosis, Gonadotropin Inhibition and Polycystic Ovary Syndrome.

US matches:

  • Reclipsen

Ingredient matches for Reclipsen



Desogestrel

Desogestrel is reported as an ingredient of Reclipsen in the following countries:


  • United States

Ethinylestradiol

Ethinylestradiol is reported as an ingredient of Reclipsen in the following countries:


  • United States

International Drug Name Search

No comments:

Post a Comment